During the past decade, Via Christi Regional Medical Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 84 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 35 clinical trials were completed. i.e. 875% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Via Christi Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Children's Oncology Group" with 11 trials sponsored and "Gynecologic Oncology Group" with 11 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Via Christi Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Via Christi Regional Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Colorectal Cancer" (8 trials), "Breast Cancer" (7 trials), "Leukemia" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Via Christi Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Via Christi Regional Medical Center" are "Drug" (108 trials), "Other" (64 trials), "Biological" (38 trials), "Procedure" (19 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (16 trials), "Placebo" (13 trials), "Paclitaxel" (12 trials) and "leucovorin calcium" (10 trials). Other intervention names were less common.

The vast majority of trials in "Via Christi Regional Medical Center" are 102 trials for "All" genders, 29 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Via Christi Regional Medical Center". undefined are not yet recruiting, 3 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Via Christi Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Via Christi Regional Medical Center, 9 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".